Skip to main content
# Title Research Year
81 Survival of High Grade Glioma Patients Treated by Three Radiation Schedules
with Chemotherapy: A Retrospective Comparative Study
2017
82 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
83 Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma 2017
84 Gemcitabine plus Paclitaxel versus Paclitaxel Monotherapy in
Patients with Metastatic Breast Cancer
2017
85 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
86 Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma 2017
87 Gemcitabine plus Paclitaxel versus Paclitaxel Monotherapy in
Patients with Metastatic Breast Cancer
2017
88 Brain SPECT/CT scanning with technetium-99m pentavalent dimercaptosuccinic acid [DMSA (V)] is an accurate tool for post-treatment evaluation of patients with glioma. 2017
89 Brain SPECT/CT scanning with technetium-99m pentavalent dimercaptosuccinic acid [DMSA (V)] is an accurate tool for post-treatment evaluation of patients with glioma. 2017
90 The Prognostic Impact of Neutrophil Lymphocytic Ratio (NLR)
o n
Survival of Patients with Glioblastoma Multiforme (GBM): A
Retrospective Cohort Study
2017